High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$15.0M
$15,039,221
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CYTK |
CYTOKINETICS INC
|
CEO
Sell to Cover
|
2026-03-09 | $481,570 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-09
$156,779
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-09 | $156,779 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Sell to Cover
2026-03-09
$176,513
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Sell to Cover
|
2026-03-09 | $176,513 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-03-05
$779,330x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-03-05 | $779,330x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
2026-03-05
$1,608,730Largex2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
|
2026-03-05 | $1,608,730Largex2 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-03-02
$33,340
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-03-02 | $33,340 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-03-02
$54,595
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-03-02 | $54,595 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -21.8%
|
2026-03-02 | $306,050 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-02-05
$348,900
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-02-05 | $348,900 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -22.9%
2026-02-05
$928,950
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -22.9%
|
2026-02-05 | $928,950 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-02-02
$33,340
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-02-02 | $33,340 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-02-02
$55,021
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-02-02 | $55,021 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Equity Compensation
2026-01-02
$33,303x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Equity Compensation
|
2026-01-02 | $33,303x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2026-01-02
$112,585x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2026-01-02 | $112,585x2 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
CEO
Equity Compensation
|
2025-12-22 | $475,124x4 | M | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
Equity Compensation
|
2025-12-22 | $152,200x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
WIERENGA WENDELL
• Director
10b5-1 SellΔOwn -38.1%
2025-12-22
$1,322,800Large
|
||||||
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -38.1%
|
2025-12-22 | $1,322,800Large | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Equity Compensation
2025-12-16
$23,320x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Equity Compensation
|
2025-12-16 | $23,320x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-12-16
$134,728
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-12-16 | $134,728 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Equity Compensation
2025-12-08
$40,773x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Equity Compensation
|
2025-12-08 | $40,773x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 Sell
2025-12-08
$68,730
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 Sell
|
2025-12-08 | $68,730 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Equity Compensation
2025-12-05
$1,775,998Largex8
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Equity Compensation
|
2025-12-05 | $1,775,998Largex8 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -50.9%
2025-12-05
$3,461,452Large
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -50.9%
|
2025-12-05 | $3,461,452Large | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
Equity Compensation
|
2025-12-02 | $87,500x2 | M | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -10.5%
|
2025-12-02 | $559,125 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Equity Compensation
2025-12-02
$23,320x2
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Equity Compensation
|
2025-12-02 | $23,320x2 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-12-02
$140,558
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-12-02 | $140,558 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Harrington Robert Arthur
• Director
10b5-1 SellΔOwn -10.4%
2025-12-01
$143,620
|
||||||
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -10.4%
|
2025-12-01 | $143,620 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
Equity Compensation
|
2025-12-01 | $384,994x4 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -73.8%
2025-12-01
$1,872,430Large
|
||||||
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -73.8%
|
2025-12-01 | $1,872,430Large | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -17.9%
|
2025-11-19 | $323,650 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Other
2025-11-18
$23,320
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Other
|
2025-11-18 | $23,320 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-11-18
$146,190
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-11-18 | $146,190 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
Other
|
2025-11-11 | $49,990 | M | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -34.1%
|
2025-11-11 | $336,789 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Other
2025-11-04
$24,327
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Other
|
2025-11-04 | $24,327 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-11-04
$136,667
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-11-04 | $136,667 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
CEO
10b5-1 Sell
|
2025-10-30 | $314,300 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
Other
|
2025-10-27 | $43,750 | M | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -11.9%
|
2025-10-27 | $256,725 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Other
2025-10-21
$22,313
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Other
|
2025-10-21 | $22,313 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-10-21
$122,553
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-10-21 | $122,553 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
CEO
10b5-1 Sell
|
2025-10-16 | $300,150 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Other
2025-10-07
$21,200
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Other
|
2025-10-07 | $21,200 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-10-07
$121,120
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-10-07 | $121,120 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -40.9%
|
2025-10-06 | $405,420 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
CEO
10b5-1 Sell
|
2025-10-01 | $275,250 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
Director
10b5-1 SellΔOwn -28.8%
|
2025-09-30 | $368,761 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Other
2025-09-23
$21,200
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Other
|
2025-09-23 | $21,200 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
10b5-1 Sell
2025-09-23
$98,560
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
10b5-1 Sell
|
2025-09-23 | $98,560 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
CEO
10b5-1 Sell
|
2025-09-15 | $248,850 | S | Form 4 |